The move comes in response to growing American and Canadian investments in facilities to increase domestic production.

Intel Corporation is set to face intense investor scrutiny over its ongoing CEO search and turnaround strategy as it prepares to report quarterly earnings on Thursday. The company is grappling with ...

Advanced Therapeutics Pharmaceutical Outsourcing IndustryFuture Market Insights (FMI), a leading provider of industry analysis and market research, has unveiled its latest report highlighting the ...

Lonza Group has been a dominant player in the contract development and manufacturing space for decades. We think the outlook for Lonza looks bright, especially as drug manufacturing becomes more ...

One positive of the last election is that the Trump administration is pro-US manufacturing and is considering tax incentives to reward companies that manufacture in the US and tariffs to punish ...

Study Forecasts 7.0% CAGR, with the CDMO Market Expanding from $136.6 Billion in 2024 to $191.6 Billion by 2029, Fueled by Increased Demand for Outsourced Drug Development and Manufacturing.Boston, ...

Lantheus is acquiring radiopharmaceutical CDMO Evergreen Theragnostics in a deal worth up to $1 billion, expanding its manufacturing capabilities and drug pipeline. The acquisition includes Octevy, a ...

From HCLTech’s side, Ashish Kumar Gupta, Head for EMEA and corporate VP, who was instrumental in stitching the deal 2016, is ...

HCLTech aims to retain its $1 billion contract with Volvo Group as Infosys emerges as a strong contender. The negotiators met ...

The week’s big story has been about China’s DeepSeek low-cost AI model. Because DeepSeek requires fewer advanced chips, its ...

The week’s big story has been about China’s DeepSeek low-cost AI model. Because DeepSeek requires fewer advanced chips, its ...